ABVC BioPharma Inc

-0.01 (-0.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)62.89M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.14 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$2.73
50-Day MAN/A
200-Day MAN/A
See more pivots

ABVC BioPharma Inc Stock, NASDAQ:ABVC

44370 Old Warm Springs boulevard, 44370 Old Warm Springs Boulevard, Fremont, California 94538
United States of America
Phone: +1.845.291.1291
Number of Employees: 34


ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of new drugs and medical devices. The company also integrates research achievements from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. It conducts clinical trials of translational medicine for Proof of Concept and out-licenses it to international pharmaceutical companies. Its products include BLI-1005 CNS-Major Depressive Disorder; BLI-1008 CNS-Attention Deficit Hyperactivity Disorder; BLI-1401-1 Anti-Tumor Combination Therapy-Solid Tumor with Anti-PD-1; BLI-1401-2 Anti-Tumor Combination Therapy-Triple Negative Breast Cancer; and BLI-1501 Hematology-Chronic Lymphocytic Leukemia. The company was founded in 1990 and is headquartered in Fremont, CA.